- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- News News
- Join Join
By Jonathan D. Salant for NJ.Com
"Public opinion is changing on this issue," said Rep. Matt Gaetz, R-Fla., the chief sponsor of the Medical Cannabis Research Act, which authorizes research into the medical benefits of marijuana. "Congress is behind. We need to catch up.
"Two pro-marijuana groups, the National Cannabis Industry Association and Americans for Safe Access, held press conferences and met with federal lawmakers on Capitol Hill.
"Public opinion is changing on this issue," said Rep. Matt Gaetz, R-Fla., the chief sponsor of the Medical Cannabis Research Act, which authorizes research into the medical benefits of marijuana. "Congress is behind. We need to catch up."
Two pro-marijuana groups, the National Cannabis Industry Association and Americans for Safe Access, held press conferences and met with federal lawmakers on Capitol Hill.
Combined, they brought about 400 people to Washington. "It's about making sure they're acting on the wishes of their constituents," said one of them, Noah Mamber, a lawyer from Franklin Lakes.
Legalizing weed is 'not a matter of if, but when,' Booker says
U.S. Sen. Cory Booker said Congress is moving toward ending the federal prohibition on marijuana.
Their agenda included Gaetz's research act -- he spoke at both press conferences --as well as bills preventing the federal government from enforcing its prohibition in states that have legalized the drug and allowing marijuana businesses to act just like everyone else with checking accounts and credit cards.
"It is basically inevitable that federal law will yield to the states," said Aaron Smith, executive director of the cannabis industry trade group.
"We're seeing more and more members coming to the table," Lee said. "We're opening doors to research. We're saying to the federal government, 'Stop meddling in state and local cannabis laws."
Rep. Earl Blumenauer, a co-founder of the Congressional Cannabis Caucus, called the effort to legalize marijuana "one of the most dynamic movements taking place across the county."
"It's been fascinating to watch," said Blumenauer, D-Ore.
Rep. Lou Correa, D-Calif., pointed to the Capitol building that formed the backdrop when he spoke.
"You have a big job to do," he told the advocates. "Your mission is simple: Let them in the building know what the will of the people is."